{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:20:59Z","timestamp":1740122459530,"version":"3.37.3"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-023-02857-z","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T04:02:06Z","timestamp":1688443326000},"page":"411-413","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Usefulness of the PRECISE-DAPT score at differentiating between ticagrelor and prasugrel for dual antiplatelet therapy initiation"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0047-7453","authenticated-orcid":false,"given":"Avik","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7396-4140","authenticated-orcid":false,"given":"Ahmad","family":"Najmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8797-3216","authenticated-orcid":false,"given":"Gaurav","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3211-1122","authenticated-orcid":false,"given":"Ratinder","family":"Jhaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balakrishnan","family":"Sadasivam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,4]]},"reference":[{"issue":"10","key":"2857_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.amjcard.2022.04.040","volume":"176","author":"G Ndrepepa","year":"2022","unstructured":"Ndrepepa G, Lahu S, Aytekin A et al (2022) One-year ischemic and bleeding events according to renal function in patients with Non-ST-Segment elevation Acute coronary syndromes treated with percutaneous coronary intervention and third-generation antiplatelet drugs. Am J Cardiol 176(10):15\u201323. https:\/\/doi.org\/10.1016\/j.amjcard.2022.04.040","journal-title":"Am J Cardiol"},{"issue":"24","key":"2857_CR2","doi-asserted-by":"publisher","first-page":"e027257","DOI":"10.1161\/JAHA.122.027257","volume":"11","author":"S Lahu","year":"2022","unstructured":"Lahu S, Scalamogna M, Ndrepepa G et al (2022) Prior myocardial infarction and treatment effect of Ticagrelor Versus Prasugrel in patients with Acute Coronary Syndromes - a post-hoc analysis of the ISAR-REACT 5 Trial. J Am Heart Assoc 11(24):e027257. https:\/\/doi.org\/10.1161\/JAHA.122.027257","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"2857_CR3","doi-asserted-by":"publisher","first-page":"e012204","DOI":"10.1161\/CIRCINTERVENTIONS.122.012204","volume":"15","author":"S Lahu","year":"2022","unstructured":"Lahu S, Presch A, Ndrepepa G et al (2022) Ticagrelor or Prasugrel in patients with Acute Coronary Syndrome and high bleeding risk. Circ Cardiovasc Interv 15(10):e012204. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.122.012204","journal-title":"Circ Cardiovasc Interv"},{"issue":"9","key":"2857_CR4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/ehjacc\/zuac095","volume":"11","author":"SJ Godtfredsen","year":"2022","unstructured":"Godtfredsen SJ, Kragholm KH, Leutscher P et al (2022) Effectiveness and safety of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a nationwide registry-based study. Eur Heart J Acute Cardiovasc Care 11(9):697\u2013705. https:\/\/doi.org\/10.1093\/ehjacc\/zuac095","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"10073","key":"2857_CR5","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","volume":"389","author":"F Costa","year":"2017","unstructured":"Costa F, van Klaveren D, James S et al (2017) Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet 389(10073):1025\u20131034. https:\/\/doi.org\/10.1016\/S0140-6736(17)30397-5","journal-title":"Lancet"},{"issue":"23","key":"2857_CR6","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J et al (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123(23):2736\u20132747","journal-title":"Circulation"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02857-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-023-02857-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02857-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T20:22:24Z","timestamp":1692390144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-023-02857-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,4]]},"references-count":6,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["2857"],"URL":"https:\/\/doi.org\/10.1007\/s11239-023-02857-z","relation":{},"ISSN":["1573-742X"],"issn-type":[{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2023,7,4]]},"assertion":[{"value":"22 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosures"}}]}}